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The gastric H,K-ATPase in stria vascularis
contributes to pH regulation of cochlear
endolymph but not to K secretion
Hiromitsu Miyazaki1,2,3, Philine Wangemann2 and Daniel C. Marcus1*
Abstract
Background: Disturbance of acid–base balance in the inner ear is known to be associated with hearing loss in a
number of conditions including genetic mutations and pharmacologic interventions. Several previous physiologic
and immunohistochemical observations lead to proposals of the involvement of acid–base transporters in stria
vascularis.
Results: We directly measured acid flux in vitro from the apical side of isolated stria vascularis from adult C57Bl/6
mice with a novel constant-perfusion pH-selective self-referencing probe. Acid efflux that depended on metabolism
and ion transport was observed from the apical side of stria vascularis. The acid flux was decreased to about 40 %
of control by removal of the metabolic substrate (glucose-free) and by inhibition of the sodium pump (ouabain).
The flux was also decreased a) by inhibition of Na,H-exchangers by amiloride, dimethylamiloride (DMA), S3226 and
Hoe694, b) by inhibition of Na,2Cl,K-cotransporter (NKCC1) by bumetanide, and c) by the likely inhibition of HCO3/
anion exchange by DIDS. By contrast, the acid flux was increased by inhibition of gastric H,K-ATPase (SCH28080) but
was not affected by an inhibitor of vH-ATPase (bafilomycin). K flux from stria vascularis was reduced less than 5 %
by SCH28080.
Conclusions: These observations suggest that stria vascularis may be an important site of control of cochlear
acid–base balance and demonstrate a functional role of several acid–base transporters in stria vascularis, including
basolateral H,K-ATPase and apical Na,H-exchange. Previous suggestions that H secretion is mediated by an apical
vH-ATPase and that basolateral H,K-ATPase contributes importantly to K secretion in stria vascularis are not supported.
These results advance our understanding of inner ear acid–base balance and provide a stronger basis to interpret the
etiology of genetic and pharmacologic cochlear dysfunctions that are influenced by endolymphatic pH.
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Background
Disturbance of acid–base balance in the inner ear is
known to be associated with hearing loss in a number of
conditions including genetic mutations (e.g., Pendred
syndrome and hereditary distal renal tubular acidosis
[1–4]) and pharmacologic interventions (e.g., acidic-
vehicle drug delivery [5, 6]). Homeostasis of endo-
lymphatic (luminal) pH by specific ion transporters in
cochlear epithelial cells has been postulated and observed.
H+ secretion by marginal cells of the stria vascularis was
proposed based on observations of immunostaining of
vH+-ATPase near the apical membrane of the epithe-
lial cells [3, 7]. H+,K+-ATPase [8] and Na+,H+ exchangers
[9–11] have been immunolocalized to strial marginal cells
and both Na+,H+ exchanger [12] and H+-monocarboxylate
transporter [13] activity have been observed. A counter-
balancing secretion of HCO3
− by apical pendrin (SLC26A4)
in strial spindle cells, spiral prominence and outer sulcus
cells is also critical to pH homeostasis and hearing [14].
The goal of the present study was to test the proposi-
tions that the stria vascularis secretes H+ via vH+-ATPase,
and that the basolateral H+,K+-ATPase in strial marginal
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cells provides a third K+ uptake pathway (in addition
to the Na+,2Cl−,K+ cotransporter (NKCC1) and Na+,K
+-ATPase) involved in K+ secretion. We demonstrate
that the stria vascularis can indeed actively secrete H+, but
via apical Na+,H+ exchange and not vH+-ATPase. The
basolateral H+,K+-ATPase can contribute to this H+
secretory flux, but does not mediate a significant basolat-
eral K+-uptake in parallel to the other two K+-secretory
uptake pathways. Further, the apical Na+,H+ exchanger is
poised to aid Na+ removal during pathological elevation of
endolymphatic Na+. These results advance our under-
standing of inner ear acid–base balance by rejecting some
prevailing concepts and by confirming others.
Methods
Tissue preparation
Adult C57Bl/6 mice of both genders were deeply anes-
thetized with 4 % tribromoethanol (0.014 ml/g body wt
ip) and sacrificed by decapitation according to a protocol
approved by the Kansas State University Institutional
Animal Care and Use Committee (#2925). The handling
of animals adhered to the ARRIVE guidelines. Stria
vascularis (without spiral ligament) was microdissected
from the cochlea. Stria vascularis was folded with the
apical membrane to the outside of the loop and then
mounted in a superfusion chamber on the stage of an
inverted microscope and stabilized in the bath with a
glass holding pipette.
Transepithelial hydrogen and potassium fluxes
K+ secretion by inner ear epithelia was measured by
techniques well-established in this laboratory [15] and
extended in this study to also measure H+ fluxes. Briefly,
glass capillaries were pulled to a tip size of about 4 µm
and silanized, filled with reference electrolyte (K+:
100 mM KCl in 0.2 % agar; pH: 500 mM KCl +20 mM
hepes, pH 7.34 in 0.2 % agar), a short column of liquid
ion exchanger (K+, potassium ionophore I-cocktail B:
50–100 μm column of Sigma-Fluka #99373; pH, hydro-
gen ionophore II: 20–30 μm column of Sigma-Fluka
#95297) aspirated into the tip and the electrode was
connected to an electrometer headstage via a Ag/AgCl
wire in contact with the reference electrolyte. The
ground was a Ag/AgCl wire connected to the bath via a
1 M KCl agar bridge.
The electrodes were first tested for a macroscopic
slope of 50–60 mV/decade concentration change and
then tested for their ability to detect a gradient near an
artificial source (Fig. 1a). The artificial source was con-
structed from a glass pipette (~80 μm tip diameter) filled
with 100 mM KCl or 2 mM H2SO4 solution at pH ~3.6
in 4 % agar, which permitted testing drugs for contribut-
ing any additional pH buffering or for interference with
the liquid ion exchanger. The tip of the ion-selective
electrode was positioned under visual control to within
a few micrometers of the apical cell surface or the orifice
of the artificial source. The electrode was then oscillated
by linear translation stages via computer-controlled step-
per motors a distance of 30 μm away from the tissue or
source. The electrode signal was recorded at each of
these two positions and the difference calculated at inter-
vals of 6.8 s to obtain a representation of the relative flux
of K+ or H+ [16]. This difference voltage was also obtained
remote from the source (~500 μm) to establish the zero-
flux baseline.
Tissues were fixed to the bottom of a microscope cham-
ber and superfused with solutions at 37 °C. The super-
fusion solution reached both the apical and basolateral
membranes of the marginal cells, since it was determined
earlier that dissection of the stria from the spiral liga-
ment compromises the integrity of the basal cell layer
[17]. H+ flux was measured (Fig. 1b) in a weakly-buff-
ered perilymph-like solution (below) to which transport
inhibitors were added. Perfusion conditions were carefully
adjusted to obtain the best compromise between good
fluid exchange and maintenance of sufficient unstirred
layer to establish a measureable concentration gradient
near the tissue. Data are expressed as the difference in
voltage of the ion-selective electrode across the 30 μm ex-
cursion or as the fraction (in %) of that voltage difference
under test conditions compared to the value during the
control period.
The bath solutions contained (in mM): 150 NaCl, 1.6
K2HPO4, 0.4 KH2PO4, 0.7 CaCl2, 1.0 MgCl2, 5 glucose,
pH 7.4 (by NaOH). Measurements were made at 37 °C.
Drugs were either pre-dissolved in DMSO [amiloride
(Sigma A7410), HOE694 (3-methylsulfonyl-4-piperidino-
benzoyl) guanidine methanesulfonate; gift from Dr. H-J.
Lang), S3226 (3-[2-(3-guanidino-2-methyl-3-oxo-prope-
nyl)-5-methy]-N-isopropylidene-2-methyl-acrylamide; gift
from Sanofi-Aventis Deutschland GmbH), dimethyla-
miloride (DMA; Sigma A4562), ouabain (Sigma O3125),
bumetanide (Sigma B3023), SCH28080 (Sigma S4443),
DIDS (4,4’-Diisothiocyanatostilbene-2,2’-disulfonic acid;
Sigma D3514)] and used at a final concentration of < =0.1 %
DMSO or dissolved directly in bath solution [bafilomycin
A1 (Sigma B1793)]. DMSO 0.1 % was also added to the
control solution when it was used to dissolve the drug.
Tissues were superfused with the control bath solution
(above) for at least 5 min to stabilize the preparation,
followed by a 5-min first measurement period, then a 5
to 10 min experimental treatment period, followed by a
second 5-min control period. Thirteen to 18 continuous
digital samples were averaged near the end of the period
prior to the experimental period and from a stable or
early quasi-stable time period, typically 3 to 5 min post
solution change. When there was a slow secondary
phase to the experimental response, an earlier quasi-
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stable time period was chosen in order to minimize pos-
sible drift in the experiment or changes due to second-
ary effects from the experimental treatment [see
Additional file 1].
Measurements from the experimental period were
compared to the value from the prior period (time-
control, glucose-free, ouabain, 50–200 μM bumeta-
nide, DIDS, bafilomycin) or to the average of the two
control periods when the response was clearly revers-
ible (amiloride and its analogs, SCH28080, 1–10 μM
bumetanide). Data are expressed as mean ± sem of the
signal in μV or percent of the control, n = number of
tissue samples [see Additional file 1].
Significance was determined by paired t-test and
P < 0.05 was taken as a significant difference. Concentration-
response data for SCH28080 and the NHE transport in-
hibitors were fitted to Michaelis-Menton kinetics using
Origin software (OriginLab, Northampton, MA). The fits
were made using the individual data points in order to
avoid skewed weighting on the logarithmic scale and the
best-fit curve then plotted with the average response at
each concentration for clarity.
Results and discussion
Strial H+ flux is linked to metabolism and Na+,K+-ATPase
activity
H+ flux was measured near the apical membrane of stria
vascularis and the results were not significantly affected
by the experimental protocol (Fig. 2a). A substantial H+
flux was observed, as indicated by a mean voltage differ-
ence at the H+-selective microelectrode of 32.6 ± 0.8 μV
(n = 118) under control conditions. Both glucose-
removal and inhibition of the basolateral Na+,K+-ATPase
with ouabain (1 mM) reduced apical H+ flux to 37.9 ±
0.6 % (n = 3) and to 39.7 ± 2.2 % (n = 3) of control values
(Fig. 2b, c, d). These results are consistent with the inter-
pretation 1) that strial H+ flux requires metabolic energy
and 2) that it depends on a transmembrane Na+ gradient
established by the Na+-pump. The remaining ~40 % H+
flux after removal of glucose may represent catabolism
of other stored metabolic substrates, including glycogen
or phosphocreatine, although glycogen stores in the stria
Fig. 1 Self-referencing ion-selective electrode method. The electrode
(probe) tip oscillates a distance of about 30 μm (double-headed
arrow). The mean position is first set remote from the source
(about 500 μm away; not shown) and the difference signal from the
oscillation is taken as zero. The oscillating probe is then set within
several μm of the a artificial source or b epithelium, and the
difference signal in the concentration gradient is taken as a relative
measure of the ion flux. Changes in ion flux are monitored during
bath perfusion of control and experimental solutions. (Top panels)
diagram; (Bottom panels) photomicrographs of artificial and epithelial
sources and adjacent probe. Liquid ion exchanger (selective for K+
or H+) is visible in the tip of the electrode
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vascularis are quite low compared to other inner ear
structures [18]. The transport pathway of this remaining
H+ flux is not yet identified, but may be simple diffusion
through H+ channels [19] or through other integral
membrane proteins [20].
The primary metabolic source of secreted acid is the
unusually-high rate of CO2 production from glucose,
thought to be due to shunting of glycolysis through the
hexose monophosphate pathway [21]. Strial metabolism
occurs at a remarkably-high rate, similar to that of
kidney [22]. The rate of O2 consumption decreases by
about half when the Na+-pump is blocked by ouabain
[22]. The coupling of O2 respiration rate to CO2 produc-
tion with a respiratory quotient of 1.2 [21] predicts a
drop of H+ efflux by ouabain of a little more than half,
which is consistent with our observation (above).
Strial H+ flux is not carried by an apical vH+-ATPase
The apical H+ flux in the presence of 1 μM bafilomycin
A1, a concentration that would produce a near maximal
inhibition of H+-ATPase, was not significantly different
than under control conditions (Fig. 2d). This result
demonstrates that H+ flux is not mediated via an apical
vH+-ATPase and suggests that the immunostained vH
+-ATPase near the apical membrane of marginal cells [7]
is not contributing to H+ efflux under our experimental
conditions. It is conceivable that the immunostained vH
+-ATPase is in sub-apical vesicles [23].
Coupling of strial K+ flux to H+ flux
The effect of ouabain on H+ flux (above) is consistent
with a feedback of cellular ion transport to the rate of
metabolism needed to power the transport. We evalu-
ated specifically the primary ion transport function of
stria (K+ secretion) by inhibiting apical K+ flux from
strial marginal cells by blocking uptake of K+ via the
basolateral Na+,2Cl−,K+ cotransporter with bumetanide
(Fig. 3a, b). The average from all measurements of K+
flux under control conditions was 5.6 ± 0.4 μV (n = 28).
The IC50 of bumetanide on K
+ flux in this series of ex-
periments was 7 × 10−6 M, which is consistent with spe-
cific inhibition of NKCC1, and is similar to previous
findings in vestibular dark cells and strial marginal cells
[17, 24, 25]. Indeed, inhibition of K+ secretion by bumet-
anide partially inhibited H+ flux (Fig. 3d). This finding is
consistent with the view that K+ secretion is coupled to
metabolic rate and thereby acid production and its sub-
sequent efflux from the cells. The meaning of the obser-
vation that H+ flux is reduced far more by ouabain than
by bumetanide is not clear. These results are consistent
Fig. 2 H+-flux from stria vascularis; control, glucose-free, ouabain and bafilomycin. a Summary traces (N = 4) of time-controls during perfusion of
control bath solution in the absence of any experimental agents. Boxes labeled C1 and C2 are the perfusion times from two separate reservoirs
of bath solution (see Methods for composition). b Summary traces (N = 3) of glucose-free (0-glucose) perfusion. c Summary traces (N = 3) of
ouabain (1 mM) perfusion. d Bar graphs of steady state effects of time-control, glucose-free, ouabain and bafilomycin (1 μM; N = 6) perfusion. *,
P < 0.05; ns, not significant. a, b, c Traces are the vertical averages of N experiments conducted with identical time-course. Standard error bars are
indicated only at intervals for clarity; boxes show duration of the experimental period
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with the notion that the Na+ pump energizes more pro-
cesses than K+ secretion, such as the Na+,H+ exchangers
(below) and/or other Na+-coupled transport [26].
We hypothesized that since reduction of metabolism
(either by direct inhibition of metabolism or via in-
hibition of ion transport) lead to reduced apical H efflux,
that stimulation of ion transport was expected to in-
crease apical H efflux. DIDS stimulates K+ secretion
through potentiation of apical KCNQ1/KCNE1 K+ chan-
nels [27] as well as its more-widely known inhibitory
action on several types of Cl−-HCO3
− transporters, in-
cluding Slc26a4 [2, 28]. It was expected that if the
primary action of DIDS were stimulation of K+ secre-
tion, the metabolic rate would be increased and thereby
increase the apical H+ flux. By contrast, it was observed
that DIDS (1 mM), similar to bumetanide, reduced the
H+ flux from strial marginal cells (Fig. 3d).
This result is inconsistent with our hypothesis and
suggests that the primary effect of DIDS may be via its
known inhibition of several anion transporters [28]. The
drug target is not likely to be the Cl−,HCO3
− exchanger
Slc26a4, since Slc26a4 is not expressed in strial marginal
cells, and even if HCO3
− secretion by apical Slc26a4 in
remote cells contributed to the net H+ flux recorded at
the marginal cells, inhibition by DIDS would lead to an
increase of net H+ flux, and not the observed decrease.
One could therefore speculate that there is normally a
DIDS-sensitive basolateral HCO3
− efflux (e.g., via NBCe1
as proposed in the proximal kidney tubule [28]) from
strial marginal cells. Inhibition by DIDS of this putative
basolateral HCO3
− efflux would result in an accumulation
of intracellular HCO3
− which would be expected to slow
down the hydrating reaction of CO2 catalyzed by car-
bonic anhydrase, thereby reducing the available cytosolic
H+ and apical H+ efflux, as observed. The unreacted
CO2 would diffuse passively across the basolateral mem-
brane and be carried away in the blood (in vivo) or bath
(in vitro). The actual mechanism remains unknown.
Strial H+ flux is carried by apical Na+,H+ exchangers
It was hypothesized that apical H+ efflux may be medi-
ated by Na+,H+-exchangers (NHEs) in the apical mem-
brane. Indeed, our results support the participation of
NHEs in H+ secretion although the specific isoform(s)
involved were not unambiguously determined. We found
the apical H+ flux in strial marginal cells was reduced by
several inhibitors of NHEs, including amiloride, dimethy-
lamiloride (DMA), S3226 and Hoe694 (Fig. 4). The
amiloride analogs employed here are more specific for the
NHEs than is amiloride itself. Amiloride has additional
inhibitory properties against the epithelial sodium channel
(ENaC) and Na+,Ca2+-exchangers [29]. Dose–response
Fig. 3 K+- and H+- fluxes from stria vascularis; bumetanide and DIDS. a and c K+ flux; b and d H+ flux. a Summary traces (N = 7) of effect of
perfusion of bumetanide (50 μM; bumet) on K+ flux from stria vascularis. b Summary traces (N = 6) of effect of perfusion of bumetanide (50 μM)
on H+ flux from stria vascularis. c Concentration-response curve for bumetanide on K+ flux from stria vascularis fit by the Michaelis-Menton
equation (N = 5–6). d Bar graph summaries of steady–state effects of bumetanide (50 μM; N = 6; Bumet) and DIDS (1 mM; N = 6) on H+ flux from
stria vascularis. *, P < 0.05; ns, not significant. a, b: boxes show duration of the experimental period
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curves for DMA and S3226 were fitted by the Michaelis-
Menton equation for two drug targets that contributed
18 % (high affinity) and 82 % (low affinity) of H+ flux. The
high affinity target had an IC50 of 3 × 10
−7 for DMA
and 3 × 10−6 for S3226. The low affinity targets were taken
to be in metabolic pathways rather than membrane trans-
porters; interference with metabolism was shown to de-
crease the apical H+ flux (e.g., removal of glucose, above).
High concentrations of drugs (e.g., >100 μM) that are in
equilibrium with a lipophilic chemical form (e.g., DIOA
and NPPB) [30, 31], are able to integrate into mitochon-
drial membranes and interfere with ATP production.
Studies on NHE function have often been performed
in cells which express multiple isoforms of NHE, which
complicates the unambiguous identification of the active
isoform(s). Other complicating factors include the strong
dependence of the IC50 of the amiloride analogs on
extracellular [Na+], making it difficult to compare spe-
cific IC50 values for specific NHE isoforms in the litera-
ture derived under vastly different [Na+] [29].
The greater sensitivity to DMA over S3226 found here
is consistent with the H+ flux being mediated by NHE2
[29]. NHE2 is expressed in other epithelial cells and can
occur in either the apical [32] or basolateral membrane
[33]. NHE2 mRNA transcripts were present in stria vas-
cularis at age P10, determined by gene array (GEO Data
set: GSE10587). Partial inhibition of the H+ flux by the
NHE3-specific inhibitor S3226 is consistent with NHE3
also mediating a part of the flux. Strong expression of
NHE3 has been demonstrated in the apical membrane
of strial marginal cells [9].
NHE1 activity has been identified in the basolateral
membrane of vestibular dark cells (which are analogs of
strial marginal cells in the vestibular labyrinth) [12], and
transcripts of NHE1 were present in stria vascularis at
age P10 (GEO Data set: GSE10587), but its contribution,
if present, to the measurements here is clearly less than
apical NHEs since all inhibitors caused decreases in the
net flux. If basolateral NHE1 were the dominant target
of any of these inhibitors at the concentrations used, the
apical flux would have increased, as during inhibition of
basolateral H+ efflux via the H+,K+-ATPase (vide infra).
A transient decrease in Isc was observed in stria
vascularis with apical perfusion of 500 μM amiloride
[12]. The effect was smaller than seen with basolateral
perfusion and previously interpreted as only leakage or
diffusion to the basolateral side. However, the effect
could be a direct inhibition of apical NHE and conse-
quent cellular acidification via inhibited apical NHE
activity, consistent with the present results.
NHE6 and NHE9 mRNA transcripts were also present
in stria vascularis (GEO Data set: GSE10587). These
isoforms occur predominantly in intracellular organelles,
but have been observed occasionally in the plasma mem-
brane of some cells [34].
Significance of NHE in apical membrane
The H+ efflux observed in the present experiments in
vitro were conducted under conditions that reveal
and emphasize the presence of this transporter. That
is, the difference in [Na+] between the bath and mar-
ginal cell cytosol (Table 1) is sufficient to drive H+
out of the cell, leading to the observed substantial H+
secretion and to Na+ absorption. However under nor-
mal in vivo conditions, the Na+ difference is likely
reversed in direction and larger than the outward H+
difference (Table 1), assuming reasonable values for
cytosolic pH and [Na+].
Fig. 4 Inhibition by amiloride analogs of strial H+ flux from stria
vascularis. a Summary traces of perfusion of dimethylamiloride
(DMA; 30 μM; N = 5); box shows the duration of the experimental
period. b summary family of curves for four Na+,H+ exchanger
inhibitors: HOE694 (N = 3–7), amiloride (N = 4–6), S3226 (N = 3–6)
and DMA (N = 3–9). Data from DMA and S3226 were fitted with a
dual Michaelis-Menton equation consisting of one component that
contributes 18 % (putative apical NHEs) and a second component
that contributes 82 % (putative metabolic pathway target) of the
total response
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The cytosolic values in Table 1 are taken from the
accepted normative values in the literature that have
been utilized for similar calculations on directions of
transport in mammalian cells, for example cardiac cell
Na+,Ca2+ exchange and Na+,H+ exchange [35]. Even
though there were some early estimates of intracellular
Na+ concentration in stria vascularis that were greater
[36], a biochemical assay for Na+,K+-ATPase activity
versus Na+ concentration demonstrated a peak in activ-
ity at 10 mM [37], consistent with physiological control
set to a normal level of 10 mM or less.
Therefore under normal homeostatic conditions, this
apical membrane exchanger may actually provide a
counterbalance to the primary Na+ absorptive roles of
Reissner’s membrane, Claudius cells and outer sulcus
cells [38–43]. Analogous push/pull transport systems of
ion homeostasis for K+ [17, 43] and for Ca2+ [2, 44–46]
in endolymph have also been demonstrated. Although
not highly active under normative conditions, the apical
NHE is poised to respond to pathological increases in
endolymphatic [Na+], such as during vascular accidents
that cause local ischemic anoxia [47, 48]. NHE therefore
provides a controlled Na+ “leak” into endolymph under
normal homeostatic conditions and a Na+ absorptive
pathway during Na+ loading of endolymph.
In addition, the H+ flux from the lumen to the mar-
ginal cell cytosol (equivalent to HCO3
− secretion) via
NHE under normative conditions would augment the
HCO3
− secretory roles of strial spindle cells and spiral
prominence/outer sulcus cells via the pendrin HCO3
−
/anion exchange activity [49].
Strial H+ flux is carried by basolateral H+,K+ ATPase
Gastric H+,K+-ATPase (consisting of a heterodimer of
HKalpha1 and HKbetaG subunits) is expressed in the
basolateral membrane of strial marginal cells [8] and its
transport function can be inhibited by SCH28080 but
not ouabain, in contrast to the colonic H+,K+-ATPase,
which is inhibited by ouabain but completely insensitive
to SCH28080 [50]. We found that SCH28080 increased
apical H+ flux from strial marginal cells (Fig. 5).
The measurements were made over a concentration
range of 10−11 to 10−7 M (N = 3–7), with maximal effect
of 17.1 % increase and the EC50 of SCH28080 was 1.9 × 10
−9 M. This exquisite sensitivity is about 2 orders of
magnitude better than for inhibition of this ATPase in iso-
lated gastric glands, while the IC50 of the ATPase by the
protonated species of SCH28080 is about 1.5 × 10−8 M [51,
52], which is consistent with specific inhibition of this
ion pump. By contrast, it was found by Shibata et al
that a full decrease of endocochlear potential from vas-
cular or perilymphatic perfusion of SCH28080 occurred
at 3 and at 1 mM, respectively [8]. Our observed in-
crease in H+ flux suggests that blocking basolateral H+
efflux from the marginal cells re-directed the flux
through the apical membrane. An increased apical flux
during SCH28080 perfusion also implies an elevated
cytosolic [H+] to drive this transport.
Strial K+ flux is NOT carried by basolateral H+,K+ ATPase
It was proposed that the basolateral H+,K+-ATPase
contributes to transepithelial K+ secretion by taking up
K+ in parallel to the recognized action of the basolateral
Na+,2Cl−,K+ cotransporter [8]. SCH28080 at a virtually
maximal dose (10−8 M) decreased the apical K+ flux in
strial marginal cells by less than 5 % (Fig. 5). In order to
determine whether this small decrease was physiologic-
ally relevant or if it only represented a small but consist-
ent drift in that series of experiments, the sensitivity of
this test was increased by first reducing the apical K+
flux with a maximal dose (200 μM) of bumetanide. The
residual K+ flux in the presence of bumetanide was not
significantly greater than zero and there was no significant
difference by addition of SCH28080 (10−8 M). These data
demonstrate that H+,K+-ATPase contributes no more
than a minuscule fraction to K+ secretion and that H+,K
+-ATPase therefore does not provide an alternative route
in the basolateral membrane for K+ uptake to the norma-
tive route via the Na+,2Cl−,K+ cotransporter.
The report of a decrease in endocochlear potential in
response to SCH28080 was ascribed to an inhibition of
basolateral H+,K+-ATPase and a putative drop in baso-
lateral K+ uptake into strial marginal cells and conse-
quently a drop in electrogenic K+ transport [8]. The
present results argue against this interpretation. It is also
unlikely that the effect on EP is mediated by changes in
marginal cell cytosolic pH or extracellular pH. As
described above, the marginal cells possess both apical
and basolateral NHEs that could respond to increased
cytosolic acid and the KCNQ1/KCNE1 K+ channel in
Table 1 Estimated Na+ and H+ gradients across apical membrane of strial marginal cells
[H+],e-b (nM) [H+],c (nM) [Na+],e-b (mM) [Na+],c (mM) RH (c/e-b) RNa (e-b/c) Direction of transport
In vitro 34 (pH 7.4) 63 (pH 7.2) 150 10 1.85 15 Na+ in
H+ out
In vivo 32 (pH 7.5) 63 (pH 7.2) 1 10 1.95 0.1 Na+ out
H+ in
[H+], hydrogen ion concentration; [Na+], sodium ion concentration; e-b, endolymph (in vivo) or bath (in vitro); c, cytosol; RH RNa, Ratio of H+ and Na+ concentra-
tions between compartments; Direction of transport into or out of the cell across the apical membrane of strial marginal cells
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the apical membrane of these cells is relatively insensi-
tive to cytosolic acidification in the physiological range
[53]. In addition, the KCNJ10 K+ channel of the neigh-
boring intermediate cells is also relatively insensitive to
changes in extracellular pH [54].
Conclusions
We have developed a technique for the recording of
transepithelial H+ and K+ flux during continuous perfu-
sion of isolated inner ear tissues at 37 °C and applied it
to the investigation of pH homeostatic mechanisms in
the cochlea (Fig. 6). Several long-standing questions
about the mechanisms underlying cochlear pH homeo-
stasis were resolved. 1) The basolateral H+/K+-ATPase
Fig. 5 Effects of inhibition of gastric H+,K+-ATPase on H+- and
K+-fluxes from stria vascularis. a Summary traces (N = 7) of effect on
H+ flux of perfusion of SCH28080 (10 nM). Box shows the duration
of the experimental period. b Concentration-response curve
(N = 3–7) for stimulation of strial H+-flux by SCH28080. Data fit by
the Michaelis-Menton equation. c Small inhibition of K+ flux from
stria vascularis by SCH28080 (10 nM; N = 7)) and absence of effect
(SCH, SCH28080) after inhibition of K+ flux by bumetanide (200 μM;
N = 6; bumet). *, P < 0.05; ns, not significant
Fig. 6 Cell model of H+ and K+ secretion by strial marginal cells
in the cochlea. Transepithelial secretion of K+ is mediated by
uptake of K+ from the basolateral side of the strial marginal cells
(SMC) via the Na+,K+-ATPase and the Na+,2Cl−,K+-cotransporter
(NKCC1). The contribution to K+ flux by the gastric H+,K+-ATPase
is minimal. K+ transport from the cytosol into endolymph is
mediated by KCNQ1/KCNE1 K+ channels in the apical membrane.
Metabolically-generated acid exits the cell via the basolateral
gastric H+,K+-ATPase and the apical Na+,H+-exchangers. Apical
membrane H+ exit is increased when the basolateral H+,K
+-ATPase is inhibited and the H+ flux re-routed to the apical
membrane. Cl− that was taken up into the cytosol via the Na
+,2Cl−,K+-cotransporter is recycled across the basolateral
membrane via the ClC-K/barttin Cl− channels. Additional putative
acid/base transporters, such as basolateral DIDS-sensitive HCO3
−
efflux via NBCe1, are not shown
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of strial marginal cells was earlier posited to contribute
importantly to the cellular uptake of K+ and the subse-
quent secretion across the apical membrane. Our mea-
surements did not support that proposition, but did
demonstrate its significant contribution to basolateral H
+ flux and its coordination with apical H+ flux. 2) The
vH+-ATPase previously found near the apical membrane
of strial marginal cells was posited to contribute im-
portantly to apical H+ secretion . Our measurements did
not support that proposition. 3) Apical membranes of
strial marginal cells were previously shown to express
the Na+,H+ exchanger NHE3 and stria vascularis also
expressed mRNA of NHE1, NHE2, NHE6 and NHE9.
Our measurements support a functional H+ flux from
one or more apical Na+,H+ exchangers. These results ad-
vance our understanding of inner ear acid–base balance
and provide a stronger basis to interpret the etiology of
genetic and pharmacologic cochlear dysfunctions that
are influenced by endolymphatic pH.
Additional file
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figures. (XLSX 148 kb)
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